Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06228144 · ClinicalTrials.gov registry record · NA
Radio-Frequency Microneedling Device
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06228144: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT06228144 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06228144, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The specific aims of the study are as follows: Aim 1. Using the EC device, evaluate the cooling rate of in vivo tissue and the temperature profile of the tissue with various pre-cooling times (Phase 1). Aim 2. Using the EC device, evaluate the cooling time that is required to provide analgesia during RF microneedling at different energies (Phase 2). Aim 3. Evaluate the pain management capability of the EC device compared to the TEC device during RF microneedling when using topical anesthesia only (Phase 2). Aim 4. Determine if the EC device can eliminate the need for tumescent anesthesia and/or topical anesthesia prior to RF microneedling (Phase 2). Aim 5. Evaluate the operability and ease of use of the EC device for clinicians (Phase 2).
Interventions
- DEVICE Candela Profound System with Dermal Handpiece
- DEVICE Experimental Dermal Cooling Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2024-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06228144
The ClinicalTrials.gov registry entry for NCT06228144 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Candela Profound System with Dermal Handpiece is the first listed.
NCT06228144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06228144 about?
NCT06228144 is a clinical study titled "Radio-Frequency Microneedling Device". The specific aims of the study are as follows: Aim 1. Using the EC device, evaluate the cooling rate of in vivo tissue and the temperature profile of the tissue with various pre-cooling times (Phase 1). Aim 2. Using the EC device, evaluate the cooling time that is required to provide analgesia dur...
What is the current status of trial NCT06228144?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2024-01-31. Estimated completion is 2024-04-12.
What interventions are being tested in trial NCT06228144?
The interventions under investigation include: Candela Profound System with Dermal Handpiece (DEVICE), Experimental Dermal Cooling Device (DEVICE).
Who is sponsoring clinical trial NCT06228144?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.